VISTA PHARMACEUTICALS LTD. - Board Meeting Intimation for Approval Of Un-Audited Financial Results For The Quarter Ended 31St December, 2022

Download	< Back
07 Feb 2022
VISTA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2022 ,inter alia, to consider and approve 1. The un-audited Financial Results of the company for the quarter ended 31st December, 2021 2. To consider and take note of Limited Review Report for the quarter ended 31st December, 2021 3. Any other item with the permission of the Chairman In compliance with Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 read with SEBI (Prohibition of insider Trading) Regulations, 2015 as amended from time to time, the Company has already intimated to all its Directors, Key Management Personnel and Designated Employees regarding the Closure of the Trading Window of the Company from 01/01/2022 to 16/02/2022 (both days inclusive).
View all announcements for VISTA PHARMACEUTICALS LTD.	Source: BSE India

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us